6848.TWO RBC Bioscience Corporation

Healthcare Biotechnology Taiwan OTC Exchange
19.05 TWD
Close of Nov 6, 2026
11.77 25.75
Market cap
TWD 272M
P/E
14.0x
P/B
1.10x
ROE
17.2%
Dividend yield
4.77%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2025.

Is 6848.TWO undervalued?

Graham number
Price19.05
Graham value22.98
Discount17.1%

6848.TWO trades 17.1% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

RBC Bioscience Corporation fundamental analysis

No fundamental analysis for RBC Bioscience Corporation yet.

RBC Bioscience Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About RBC Bioscience Corporation

RBC Bioscience Corporation manufactures and sells reagents and devices for life science and molecular diagnosis. It offers robotic bench-top workstation for nucleic acid purification under the MagCore Plus II and Giga Automated Nucleic Acid Extractor names; MagCore Super Automated Nucleic Acid Extractor, an automated workstation for nucleic acid extraction; and MagCore EDA Automatic Extraction and Smart PCR Setup, an instrument for nucleic acid extraction and PCR setup pre-t…

Full company profile